Skip to main content

Aspirin as a Biological Response Modifier

  • Chapter

Abstract

For some time our laboratory has been interested in the development and control of cellular immunity, both by the thymosins and other agents. Thymosins are a family of peptide hormones produced by the thymus and thymus-derived tissues such as T lymphocytes, which modulate differentiation of a variety of T cells providing us with immunity against viruses, mycobacteria, fungi and tumors. About ten years ago, while studying thymosins, Dr. Allan Goldstein’s laboratory looked at cyclooxygenase inhibitors, among other agents, to determine whether they might influence or inhibit thymic peptides. These studies demonstrated that acetyl salicylic acid (aspirin) could enhance immune responses and synergize with thymosins.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R.S. Rappaport and G. R. Dodge, Prostaglandin E inhibits the production of human interleukin 2, J. Exp. Med. 155:943 (1982).

    Article  PubMed  CAS  Google Scholar 

  2. S. Chouaib, L. Chatenould, D. Klatzmann, et al., The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes, J Immunol. 133:1851 (1984).

    Google Scholar 

  3. J.S. Goodwin and D. R. Webb, Regulation of the immune response by prostaglandins, Clin. Immunol. Immunopath. 15:106 (1980).

    Article  CAS  Google Scholar 

  4. J. R. Vane, Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs, Nature New Biol. 231:232 (1971).

    PubMed  CAS  Google Scholar 

  5. M. M. Zatz, A. Skotnicki, J. M. Bailey, J. H. Oliver, and A. L. Goldstein, Mechanism of action of thymosin. II. Effects of aspirin and thymosin on enhancement of IL-2 production, Immunopharmacol. 9:1989 (1985).

    Article  Google Scholar 

  6. J. Hsia, N. Sarin, J. H. Oliver, and A. L. Goldstein, Aspirin and thymosin increase interleukin-2 and interferon-γ production by human peripheral blood lymphocytes, Immunopharmacol. 17:167 (1989).

    Article  CAS  Google Scholar 

  7. J. Hsia, G. L. Simon, N. Higgins, A. L. Goldstein, and F. G. Hayden, Immune Modulation by Aspirin during Experimental Rhinovirus Colds, Bull. N. Y. Acad. Med. 65:47 (1989).

    Google Scholar 

  8. J. Hsia and T. Tang, Augmentation of Influenza Vaccine Response by Aspirin, Clin. Res. in press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hsia, J., Tang, T. (1992). Aspirin as a Biological Response Modifier. In: Goldstein, A.L., Garaci, E. (eds) Combination Therapies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3340-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3340-5_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6472-6

  • Online ISBN: 978-1-4615-3340-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics